We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTB icon
5201
PUT
M&T Bank
MTB
$35.7B
$136K ﹤0.01%
800
-4,400
-85% -$714K
SMSI icon
5202
Smith Micro Software
SMSI
$14.5M
$136K ﹤0.01%
853
-61
-7% -$12.1K
ICPT
5203
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$136K ﹤0.01%
1,100
-1,200
-52% -$107K
CSLT
5204
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$136K ﹤0.01%
102,140
+51,890
+103% +$72.4K
KZR
5205
DELISTED
Kezar Life Sciences
KZR
$135K ﹤0.01%
3,381
+787
+30% +$24.2K
OVLY icon
5206
Oak Valley Bancorp
OVLY
$285M
$135K ﹤0.01%
6,952
+3,502
+102% +$62K
SRT
5207
DELISTED
Startek Inc.
SRT
$135K ﹤0.01%
16,911
+8,489
+101% +$61.9K
MGI
5208
DELISTED
MoneyGram International, Inc. New
MGI
$135K ﹤0.01%
64,401
-10,310
-14% -$33.1K
ACTG icon
5209
Acacia Research
ACTG
$428M
$134K ﹤0.01%
50,162
+25,183
+101% +$69K
BOKF icon
5210
BOK Financial
BOKF
$8.58B
$134K ﹤0.01%
1,529
-6,035
-80% -$492K
LAMR icon
5211
PUT
Lamar Advertising Co
LAMR
$16.2B
$134K ﹤0.01%
1,500
+400
+36% +$33.5K
LOPE icon
5212
PUT
Grand Canyon Education
LOPE
$3.79B
$134K ﹤0.01%
1,400
-11,800
-89% -$1.09M
MUX icon
5213
McEwen Inc
MUX
$1.03B
$134K ﹤0.01%
10,524
-12,457
-54% -$176K
SD icon
5214
SandRidge Energy
SD
$514M
$134K ﹤0.01%
31,415
+15,685
+100% +$65.5K
PHAS
5215
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$134K ﹤0.01%
21,969
+6,403
+41% +$26.4K
HSBC.PRA
5216
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$134K ﹤0.01%
5,000
ALDX icon
5217
Aldeyra Therapeutics
ALDX
$92.9M
$133K ﹤0.01%
22,926
+11,737
+105% +$67.8K
PRTK
5218
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$133K ﹤0.01%
32,999
+16,543
+101% +$57.4K
ATCO
5219
DELISTED
Atlas Corp.
ATCO
$133K ﹤0.01%
9,301
-53,402
-85% -$637K
CYOU
5220
PUT
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$133K ﹤0.01%
13,600
-133,900
-91% -$1.29M
AAWW
5221
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$133K ﹤0.01%
4,818
+4,779
+12,254% +$119K
BLUE
5222
PUT
DELISTED
bluebird bio
BLUE
$132K ﹤0.01%
116
-77
-40% -$83.7K
KGC icon
5223
CALL
Kinross Gold
KGC
$27.4B
$132K ﹤0.01%
27,900
+17,000
+156% +$76.7K
LEGH icon
5224
Legacy Housing
LEGH
$625M
$132K ﹤0.01%
7,935
+2,826
+55% +$44.3K
MKSI icon
5225
PUT
MKS Inc
MKSI
$20.1B
$132K ﹤0.01%
1,200
+600
+100% +$62.9K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.